Interstitial lung disease in rheumatoid arthritis

Kristine Phillips, Kevin R. Flaherty, Eric Lawrence Matteson, Tim Bongartz, Joan Bathon, Kevin K. Brown, Paul F. Dellaripa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Rheumatoid arthritis (RA) affects 1-2% of the general population. Although often thought of as primarily a localized inflammatory disorder with associated joint destruction, it is a diffuse systemic disease. Extra-articular manifestations of rheumatoid arthritis can be demonstrated in almost 50% of patients with RA, and include pulmonary, cardiac, ocular, renal, hematologic, and neurologic involvement. In this article, we review recent studies of interstitial lung disease (ILD) in RA with a focus on clinical and pathological features of rheumatoid arthritis associated interstitial lung disease (RA-ILD). We discuss an approach to the diagnosis and treatment of RA-ILD including potential biomarkers, and conclude by outlining areas for future research.

Original languageEnglish (US)
Pages (from-to)120-126
Number of pages7
JournalCurrent Rheumatology Reviews
Volume6
Issue number2
DOIs
StatePublished - 2010

Fingerprint

Interstitial Lung Diseases
Rheumatoid Arthritis
Joints
Nervous System
Biomarkers
Kidney
Lung
Population

Keywords

  • Interstitial lung disease
  • Pulmonary fibrosis
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Phillips, K., Flaherty, K. R., Matteson, E. L., Bongartz, T., Bathon, J., Brown, K. K., & Dellaripa, P. F. (2010). Interstitial lung disease in rheumatoid arthritis. Current Rheumatology Reviews, 6(2), 120-126. https://doi.org/10.2174/157339710791330696

Interstitial lung disease in rheumatoid arthritis. / Phillips, Kristine; Flaherty, Kevin R.; Matteson, Eric Lawrence; Bongartz, Tim; Bathon, Joan; Brown, Kevin K.; Dellaripa, Paul F.

In: Current Rheumatology Reviews, Vol. 6, No. 2, 2010, p. 120-126.

Research output: Contribution to journalArticle

Phillips, K, Flaherty, KR, Matteson, EL, Bongartz, T, Bathon, J, Brown, KK & Dellaripa, PF 2010, 'Interstitial lung disease in rheumatoid arthritis', Current Rheumatology Reviews, vol. 6, no. 2, pp. 120-126. https://doi.org/10.2174/157339710791330696
Phillips, Kristine ; Flaherty, Kevin R. ; Matteson, Eric Lawrence ; Bongartz, Tim ; Bathon, Joan ; Brown, Kevin K. ; Dellaripa, Paul F. / Interstitial lung disease in rheumatoid arthritis. In: Current Rheumatology Reviews. 2010 ; Vol. 6, No. 2. pp. 120-126.
@article{bc32b086c4324da790b9bf8635486324,
title = "Interstitial lung disease in rheumatoid arthritis",
abstract = "Rheumatoid arthritis (RA) affects 1-2{\%} of the general population. Although often thought of as primarily a localized inflammatory disorder with associated joint destruction, it is a diffuse systemic disease. Extra-articular manifestations of rheumatoid arthritis can be demonstrated in almost 50{\%} of patients with RA, and include pulmonary, cardiac, ocular, renal, hematologic, and neurologic involvement. In this article, we review recent studies of interstitial lung disease (ILD) in RA with a focus on clinical and pathological features of rheumatoid arthritis associated interstitial lung disease (RA-ILD). We discuss an approach to the diagnosis and treatment of RA-ILD including potential biomarkers, and conclude by outlining areas for future research.",
keywords = "Interstitial lung disease, Pulmonary fibrosis, Rheumatoid arthritis",
author = "Kristine Phillips and Flaherty, {Kevin R.} and Matteson, {Eric Lawrence} and Tim Bongartz and Joan Bathon and Brown, {Kevin K.} and Dellaripa, {Paul F.}",
year = "2010",
doi = "10.2174/157339710791330696",
language = "English (US)",
volume = "6",
pages = "120--126",
journal = "Current Rheumatology Reviews",
issn = "1573-3971",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Interstitial lung disease in rheumatoid arthritis

AU - Phillips, Kristine

AU - Flaherty, Kevin R.

AU - Matteson, Eric Lawrence

AU - Bongartz, Tim

AU - Bathon, Joan

AU - Brown, Kevin K.

AU - Dellaripa, Paul F.

PY - 2010

Y1 - 2010

N2 - Rheumatoid arthritis (RA) affects 1-2% of the general population. Although often thought of as primarily a localized inflammatory disorder with associated joint destruction, it is a diffuse systemic disease. Extra-articular manifestations of rheumatoid arthritis can be demonstrated in almost 50% of patients with RA, and include pulmonary, cardiac, ocular, renal, hematologic, and neurologic involvement. In this article, we review recent studies of interstitial lung disease (ILD) in RA with a focus on clinical and pathological features of rheumatoid arthritis associated interstitial lung disease (RA-ILD). We discuss an approach to the diagnosis and treatment of RA-ILD including potential biomarkers, and conclude by outlining areas for future research.

AB - Rheumatoid arthritis (RA) affects 1-2% of the general population. Although often thought of as primarily a localized inflammatory disorder with associated joint destruction, it is a diffuse systemic disease. Extra-articular manifestations of rheumatoid arthritis can be demonstrated in almost 50% of patients with RA, and include pulmonary, cardiac, ocular, renal, hematologic, and neurologic involvement. In this article, we review recent studies of interstitial lung disease (ILD) in RA with a focus on clinical and pathological features of rheumatoid arthritis associated interstitial lung disease (RA-ILD). We discuss an approach to the diagnosis and treatment of RA-ILD including potential biomarkers, and conclude by outlining areas for future research.

KW - Interstitial lung disease

KW - Pulmonary fibrosis

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=77956578646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956578646&partnerID=8YFLogxK

U2 - 10.2174/157339710791330696

DO - 10.2174/157339710791330696

M3 - Article

VL - 6

SP - 120

EP - 126

JO - Current Rheumatology Reviews

JF - Current Rheumatology Reviews

SN - 1573-3971

IS - 2

ER -